tiprankstipranks
Trending News
More News >
Protagenic Therapeutics (PTIX)
NASDAQ:PTIX
US Market

Protagenic Therapeutics (PTIX) Income Statement

Compare
70 Followers

Protagenic Therapeutics Income Statement

Last quarter (Q1 2025), Protagenic Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Protagenic Therapeutics's net income was $-1.44M. See Protagenic Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -28.22K$ 0.00$ 0.00$ -286.00
Operating Expenses
$ 5.70M$ 4.50M$ 3.56M$ 4.14M$ 2.55M
Depreciation and Amortization
$ 50.29K$ 28.22K$ 30.00$ 286.00$ 286.00
EBITDA
$ -5.47M$ -4.50M$ -3.37M$ -4.14M$ -2.55M
Operating Income
$ -5.70M$ -4.53M$ -3.56M$ -4.14M$ -2.55M
Other Income/Expenses
$ 175.61K$ -474.00K$ 2.28K$ -383.00K$ 2.88K
Pretax Income
$ -5.53M$ -5.00M$ -3.56M$ -4.52M$ -2.55M
Net Income
$ -5.53M$ -5.00M$ -3.56M$ -4.52M$ -2.79M
Per Share Metrics
Basic EPS
$ -1.13$ -1.15$ -0.83$ -1.24$ -1.08
Diluted EPS
$ -1.13$ -1.15$ -0.83$ -1.24$ -1.00
Weighted Average Shares Outstanding
4.90M 4.34M 4.32M 3.69M 2.58M
Weighted Average Shares Outstanding (Diluted)
4.90M 4.34M 4.32M 3.69M 2.58M
Currency in USD

Protagenic Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis